Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Thursday 10 September 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 465 (TSXV: $N.V) (CSE: $PAID.C) (CSE: $AUSA.C) (OTC: $AUSAF)

 Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 465 (TSXV: $N.V) (CSE: $PAID.C) (CSE: $AUSA.C) (OTC: $AUSAF)

 


Delta, Kelowna, BC, September 10, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/091020-StocksToWatch.mp3

 

Read this in full at

https://www.investorideas.com/news/2020/cannabis-potcasts/09101N-PAID-AUSA-AUSAF.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public and private company announcements.

 

Dosist™ Canada today announced a new exclusive partnership with Medical Cannabis by Shoppers Inc. to supply its innovative dose-controlled cannabis products as part of the Medical Cannabis by Shoppers™ offering.

 

Shoppers will now offer patients eight dosist product formulations, which include core formulas such as calm, rest, and soothe, all of which deliver a precise balance of THC:CBD to provide targeted results, as well as three new high potency THC-plus formulas. These formulas are administered via dosist's proprietary inhalable devices, providing patients with the first and only precision dosing inhalable products in the Medical Cannabis by Shoppers offering.

 

Since launching in 2016, dosist has become a globally recognized brand through its award-winning products, focus on testing and quality, and recognition from companies like Time and Fast Company. As the pioneer of dose-controlled cannabis technology and a leader in quality of life need-state formulations, dosist has consistently established itself as one of the top selling brands in its category in the largest legal US cannabis market (California).

 

"We are extremely proud to partner with such a trusted and respected retailer as Shoppers Drug Mart," said Gunner Winston, CEO of dosist. "Their integrity and history in providing for the medical needs of Canadians is unparalleled, and reflects very strongly our shared commitment to enabling and empowering Canadians to live better. We look forward to bringing our proprietary dose controlled products and natural formulas to Shoppers patients across the country."

 

Consistent with Shoppers' commitment to providing full product transparency, dosist is one of the only brands in Canada that posts all of its formula batch tests online, allowing patients to see that the products they are inhaling are natural and contaminant free. dosist has also partnered with Shoppers and UHN on the Medical Cannabis Real-World Evidence clinical trial, studying the effects of fully validated cannabis product on sleep, anxiety and depression.

 

"We are proud to be the only national brand to make dosist products available to Canadians who consume cannabis for medical and wellness reasons," said Ken Weisbrod, Vice President, Business Development/Cannabis Strategy, Shoppers Drug Mart. "We are pleased to bring this innovative and measured platform for cannabis use to our consumers today."

 

All dosist formulas are administered via their proprietary dose-controlled inhalable technology, which includes the new dose pen rechargeable system by dosist, an exclusive closed-loop dose pen system created by combining the dose controller and formula pods (both sold separately) for a rechargeable and flexible experience, and the dose pen 100, a sleek and convenient disposable device. Both inhalable devices deliver a precise 2.5 mg dose of formula each time, alerting the patient of a complete dose with a haptic vibration before shutting off.

 

The five dosist core formulas now available at shoppersdrugmart.ca/cannabis are:

       calm (1:6 thc-to-cbd ratio) – designed to help relax your mind and body

       soothe (2:1 thc-to-cbd ratio) – designed to help ease the mind and body

       rest (8:1 thc-to-cbd radio) – designed to help you feel rested

       bliss (9:1 thc-to-cbd ratio) – designed to help you feel just the right amount of good

       arouse (10:1 thc-to-cbd ratio) – designed to help awaken your senses and stimulate your mind

The three THC-plus formulas now available are:

       bliss thc-plus – an invigorating blend of high-potency cannabis designed to deliver feelings of euphoria and energy

       arouse thc-plus – a balanced blend of high-potency cannabis designed to deliver feelings of stimulation and clarity

       relax thc-plus – a tranquil blend of high-potency cannabis designed to deliver feelings of ease and relaxation

 

dosist products are available to patients now through the Medical Cannabis by Shoppers ecommerce site. Medical Cannabis by Shoppers Inc. provides patient access to select medical cannabis products which can be ordered online or via phone, and shipped directly and discreetly to their doorstep. The Shoppers Cannabis Care team – a dedicated call center staffed by cannabis-trained advisors and pharmacists – provides guidance and support for patients.

 

Namaste Technologies Inc.  (TSXV: N) (OTC: NXTTF), a leading online platform for cannabis products, accessories, and responsible education, today announced an agreement with Lifted Innovations Inc., a private B2C e-commerce company selling cannabis-related accessories and ancillary products in the United States and Canada. In connection with the Agreement and Namaste's strategic partner status, Lifted issued 3,065,000 common shares to Namaste, constituting, at the time of issuance, an undiluted 5% shareholding.

 

The Transaction, including the Offer, has now been completed and Namaste has received 3,065,000 common shares of PeakBirch in exchange for the Lifted Shares, constituting approximately an undiluted 3.3% shareholding of PeakBirch. The PeakBirch shares are subject to certain resale restrictions, including a 4 month hold period and a monthly limit on sales subject to certain exceptions.

 

The Agreement provides that Namaste and Lifted shall, for 24 months, collaborate wherever practicable in respect of matters of potential mutual benefit, including in respect of, the development of business in the United States, efficiencies relating to common ancillary businesses; and potential opportunities relating to the licensing of technology. The Agreement also provides a release in favour of Lifted and certain releasees from claims relating to the current or former assets or business of Lifted.

 

XTM, Inc. (CSE: PAID), a Toronto-based Fintech company in the challenger banking space, providing mobile banking and payment solutions around the world today announced it has signed a Letter of Intent ("LOI") with one of the largest online cannabis retailers in the U.S. to launch a proprietary cashless payment network.

 

This will be the first of its kind, bank grade, fully compliant, community currency, closed loop solution for any company or business looking to eliminate cash and process real-time payments including but not limited to licensed Cannabis companies.  A new web site www.CaliCard.com is being established and physical cards will soon be in production.

As part of the terms of the LOI XTM will private label its existing mobile wallet and payment network technology, finalize development for merchant settlements, arrange the banking partnerships, manage the network and license the technology to a new entity of which XTM will own 50%. The other party will adopt and roll-out the technology across all its e-commerce platforms and will leverage its contacts for sales and marketing of the solution.

Cash used in U.S. legal marijuana sales was estimated to be in excess of $8 billion in 2019. 

 

The added security risks and costs of transacting in cash are significant.  Existing solutions are overcomplicated, not fully compliant, expensive and subject to fraud and chargebacks.  Merchants say service offerings currently available to the industry are lacking in compatibility and do not provide consumers with the user experience they have come to expect in today's digital world.  They are subject to high transaction fees and are waiting for days to collect the proceeds from their sales.

 

With this new closed-loop payment network, users will quickly and easily sign up via mobile app for free.  As part of the sign-up process they will link their debit card as the method of funding the virtual card and wallet in real-time.  Merchants will receive same day settlements in a partner bank dedicated account issued to each merchant.  As well XTM is incorporating its industry leading Know Your Customer ("KYC") technology into the application to enable users to be screened for age and identity validation, dramatically reducing chargebacks and fraud.  As part of the rollout of the program each user will be delivered a physical card allowing for purchases to be made at bricks and mortar locations and will also allow access to a cash load network.

 

The Company has already received interest from other parties looking for the solution and expects to board a significant number of merchants before the end of the year.  With the current annual run rate sales of the other party and expected percentage of sales to be migrated to the platform coupled with a few additional merchants, the Company anticipates to be processing in excess of $50M in run-rate annual volume and 500K transactions per month by the end of the year.

 

XTM is looking forward to providing a positive customer checkout experience using CaliCard.com that is real-time, fully compliant and cashless and expects this will in turn significantly increase efficiencies, sales volumes and net margins for merchants.

Further details regarding the product and launch date will be announced shortly and updates will be posted on the dedicated web site www.CaliCard.com.

 

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) and its subsidiary Cocoon Technology announced the installation of CocoonPod self-service kiosks at THRIVE Cannabis Marketplace at 2755 W Cheyenne Ave, 103, North Las Vegas, NV, the first of eight locations operated by THRIVE. The launch is a positive step towards the Company's continued commitment to  U.S. focused cannabis operations.  Installations at the remaining seven locations are anticipated in the coming months.

 

"We are very pleased to have completed our first installation with THRIVE, especially with the challenges and delays Covid-19 has presented," said Max Aceituno, Chief Marketing Officer of AUSA. "Covid-19 has increased awareness and the need for social distancing and safety measures. As dispensaries begin the initial phases of reopening, CocoonPod helps mitigate the associated safety concerns while expediting the shopping experience."

 

Cocoon Technology's CocoonPod, CocoonCove, and CocoonRewards delivers interactive unattended kiosks for consumers and retailers with rich feature functionality encompassing mobile, order ahead, online delivery, loyalty, rewards, data analytics, e-wallet, ATM functionality, and cash recycling technology. Built on a cloud-based platform, Cocoon integrates with dispensary Enterprise Resource Planning (ERP) systems allowing for seamless operational efficiencies and revenue generation.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 

Tuesday 8 September 2020

Investorideas.com - Cannabis Stock News: Emerald Health Therapeutics (TSXV: EMH) (OTCQX: EMHTF) Enters into Share Purchase Agreement for Sale of Pure Sunfarms with Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFF)

Investorideas.com - Cannabis Stock News: Emerald Health Therapeutics (TSXV: EMH) (OTCQX: EMHTF) Enters into Share Purchase Agreement for Sale of Pure Sunfarms with Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFF)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 464 (NYSE: $ACB) (TSX: $ACB.TO) (OTC: $CTTH) (TSX: $WLLW.TO)

 

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 464 (NYSE: $ACB) (TSX: $ACB.TO) (OTC: $CTTH) (TSX: $WLLW.TO)

 




Delta, Kelowna, BC, September 8, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/090820-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/09081ACB-CTTH-WLLW.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public and private company announcements.

 

Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) announced an update on its business operations along with certain unaudited preliminary fiscal fourth quarter 2020 results. The Company also announced the appointment of Miguel Martin as its new CEO which is detailed in a separate announcement released this morning.

 

"Over the last six months, Aurora has focused on building the infrastructure and capabilities necessary for a successful and diversified business," stated Michael Singer, Executive Chairman and former Interim CEO of Aurora. "The first phase of our business transformation, which is now substantially complete, included the rationalization of our cost structure, reduced capital spending, and a more prudent and targeted approach to capital deployment. As a result, we now have a far more efficient asset base and infrastructure to supply our key global markets. I am delighted to now be transitioning the CEO responsibilities to Miguel and I am confident that Aurora is in a strong position to succeed under Miguel's leadership."

"Material progress has been made to optimize our Canadian operations and put Aurora on a much stronger footing," stated Miguel Martin, newly appointed CEO of Aurora. "With market leading brands and a culture rooted in innovation and science, I now feel even more confident in the opportunity to create a global leader in a rapidly growing industry."

 

Today, the Company is providing the following updates:

Preliminary Unaudited Net Revenue, Adjusted Gross Margin and SG&A Results for Q4 2020

Net revenue in Q4 2020 is expected to be between $70 million and $72 million, compared to $75.5 million in Q3 2020. Cannabis net revenue is expected to be between $66 million and $68 million, compared to $69.6 million in Q3 2020. We expect adjusted gross margin before fair value adjustments on cannabis net revenue to be within a range of 46%-50%, with lower gross margins expected from non-cannabis business segments.

 

As previously stated, Aurora has focused on prudently managing its sales, marketing and administrative ("SG&A") costs in the second half of fiscal 2020. Aurora successfully reduced SG&A costs (which include R&D spending) from over $100 million in fiscal Q2 2020 down to an expected range of $60 to $65 million in fiscal Q4 2020, excluding approximately $3 million of non-recurring costs related to the business reset and $2 million of costs associated with divested businesses.

 

Cost Rationalization and Near-Term Revenue Plan

The Company is now operating at its quarterly SG&A run-rate in the low $40 million range, and expects operational cost reductions from facility closures up to $10 million per quarter starting in the second half of fiscal 2021. With a tailwind of growth in the Canadian recreational market, the Company is better positioned for its next  phase focused on profitability.

 

Under Aurora's new CEO, the team expects to be focused on executing a tactical plan intended to (1) grow Aurora's leading market share in key profitable Canadian consumer categories (2) protect and enhance Aurora's leading market share in Canadian medical, (3) grow our international medical business and (4) build leading brands under Reliva in the US CBD market. Ultimately, Aurora believes that it is capable of supporting significantly higher levels of net revenue in the future without a corresponding level of growth in SG&A.

 

Impairment Charges

As previously announced, and as part of the business transformation and cost reset, Aurora expects to record a number of balance sheet adjustments in Q4 2020 to recognize market realities and to position the Company for future performance. These adjustments include previously announced fixed asset impairment charges, now expected to be up to $90 million, due to production facility rationalization, and a charge of approximately $140 million in the carrying value of certain inventory, predominantly trim, in order to align inventory on hand with near term expectations for demand. Approximately 40% of the expected inventory provision relates to the non-cash IFRS fair value adjustment within inventory. Although the business prospects for Aurora remain strong, under IFRS, management is required to recognize the impact of overall industry risk, and to consider the book value of the Company relative to current market capitalization. Accordingly, the Company expects to recognize a non-cash write-down of goodwill and intangible assets in the range of $1.6 to $1.8 billion.

In addition, and consistent with a focus on financial discipline and the drive to positive Adjusted EBITDA, Aurora announced today that the Company and the UFC have agreed to mutually terminate their partnership. For Aurora, this decision reflects the evolution of the realities of the cannabis market and a focus on near term profit pools. In connection with this decision, the Company expects to make a one-time payment of US$30 million to terminate the contract in Q1 2021, which is expected to avoid more than $150 million in fees, research costs, and marketing activation expenses over the next five years.

 

CTT Pharmaceutical Holdings, Inc. (OTC: CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, today announced that it has entered into a business development partnership with 3 Rivers Biotech, a pre-eminent tissue culture company. Under the agreement, 3 Rivers will leverage its network of suppliers to and manufacturers of Consumer Packaged Goods (CPG) to secure commercial partnerships based on CTT's patented sublingual wafer technology.

 

Additionally, the agreement includes the ability for CTT to utilize 3 Rivers' operational capabilities to execute technology transfers and project implementation for new customers, providing a cost-efficient and de-risked expansion of CTT's operational capacity.

3 Rivers' is one of few companies with a successful track record in the consistent, commercial-scale supply of tissue-culture-based clones for a variety of sectors, including the hemp industry. As a trusted partner, 3 Rivers is very well positioned to engage in meaningful discussions within its network to explore the potential for commercial partnerships on behalf of CTT.

 

CTT's rapidly dissolving sublingual wafers deliver active ingredients through the buccal/mucosal route, which provides a number of key advantages over other delivery mechanisms, meeting important current market dynamics. These advantages offer CPG companies the opportunity to expand their portfolios with a well-differentiated, high-margin product offering on rapidly growing market segments.

       Rapid onset CTT's strips dissolve quickly in the oral cavity (5-15 seconds), with the active ingredient rapidly absorbed into the bloodstream

       Increased bioavailability the active ingredient, once absorbed, can bypass the liver's first-pass effect, improving therapeutic outcomes and efficacy through improved bioavailability

       Safe smoke-free delivery bypassing lungs and digestive system

       Ease of use taken orally, not requiring water or swallowing

       Accurate and consistent dosing precisely determined and consistent potency of the active ingredient, a critical advantage over most other form factors

       Increased adherence the ease of use and discrete administration can help increase positive adherence outcomes

       Large target markets suitable for a wide range of applications in medical, wellness and recreational markets

 

Marc Lakmaaker, SVP Commercial Development for CTT, stated, "3 Rivers is a trusted partner at the root of the value chain for a growing number of companies in the CPG sector. Its network in large geographic markets, such as North America, China and Europe, creates a very significant opportunity for CTT to accelerate growth. The partnership also provides additional implementation bandwidth, which further de-risks our expansion efforts in a cost-effective manner."

 

Dr. Kevin Mehr, VP of Sales at 3 Rivers, added, "We believe that CTT's sublingual strips provide a unique and compelling commercial proposition for many companies in our network across a wide variety of sectors. The science behind CTT's technology, the effectiveness of its products, the Company's successful track record in bringing a new technology to market, and the caliber of its people, clearly differentiate CTT from its competition. We believe that these factors will greatly facilitate our ability to build new partnerships, and we look forward engaging with our network, on behalf of CTT."

 

Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) announced that its subsidiary - Willow Analytics Inc. - will receive advisory services and conditional funding from the National Research Council of Canada Industrial Research Assistance Program ("NRC IRAP") supporting a research and development project to advance production of its varin cannabinoids, using its proprietary biosynthetic platform.

 

"We welcome the advice and funding from NRC IRAP to support our rare cannabinoid development platform," said Dr. Mathias Schuetz, Willow's Vice-President of Research & Development. "This support is an important catalyst for us to advance our strain development capabilities and will enable us to progress from lab-scale work to pre-commercialization scale up."

 

Willow has built a strong reputation as a high-quality, high-purity biosynthetic cannabinoid producer. Its yeast fermentation production platform, initially developed for cannabigerol ("CBG") and cannabidiol ("CBD"), has shown impressive success and Willow expects to be the first company to biosynthetically produce material amounts of cannabinoids. By varying the feedstock used in its fermentation platform, the Company has made significant progress on developing strains for its varin series of cannabinoids and will use the NRC IRAP funding to accelerate the commercialization plan for these cannabinoids.

 

Trevor Peters, Willow's President & CEO, added "By using the platform technology that has allowed us to advance our CBG program ahead of schedule, we are able to expand our portfolio and pursue fermentation-based production of additional cannabinoids. We have made strong progress with our varins development to date and expect the varins program to reach scale-up phase in the first half of 2021 and market-ready levels in the second half of 2021."

 

The varins series of cannabinoids that Willow is developing include cannabigerovarin ("CBGV"), cannabidivarin ("CBDV") and tetrahydrocannabivarin ("THCV"). These varin cannabinoids are considered minor or rare cannabinoids as they occur naturally in cannabis plants at less than one percent of biomass, making them challenging and costly to produce via cultivation. Despite the lack of supply, there are advanced clinical trials and significant recreational interest due to the possible therapeutic benefits of the Varin cannabinoids, including uses for autism, diabetes and as an appetite suppressant.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:

https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 


You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB) : You can't hold a good weed stock down (Nasdaq: CG...